Literature DB >> 3556651

Retinal dysfunction in central serous retinopathy.

E L Chuang, D M Sharp, F W Fitzke, C M Kemp, A L Holden, A C Bird.   

Abstract

Patients with acute and chronic central serous retinopathy (CSR) were studied by psychophysical and photochemical means to establish the extent of visual depression and to investigate the basis of rod dysfunction in this disorder. In acute disease with serous detachment of the retina, the loss of sensitivity attains 3 log units and parallels the height of retinal elevation as does its recovery with resolution of the episode. Immediately after resolution, there is a residual 0.5 log unit threshold elevation. In chronic disease, marked loss of function exists over areas of abnormal retinal pigment epithelium in the absence of clinically detectable serous detachment. Although rhodopsin levels are low in both acute and chronic CSR, this relative lack of visual pigment does not totally account for the functional deficits in either situation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556651     DOI: 10.1038/eye.1987.18

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  12 in total

1.  High spatial resolution automated perimetry in glaucoma.

Authors:  M C Westcott; A I McNaught; D P Crabb; F W Fitzke; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy.

Authors:  L Ficker; G Vafidis; A While; P Leaver
Journal:  Br J Ophthalmol       Date:  1988-11       Impact factor: 4.638

Review 3.  [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

4.  Idiopathic multifocal choroiditis/punctate inner choroidopathy with acute photoreceptor loss or dysfunction out of proportion to clinically visible lesions.

Authors:  Marion R Munk; Jesse J Jung; Kristin Biggee; William R Tucker; H Nida Sen; Ursula Schmidt-Erfurth; Amani A Fawzi; Lee M Jampol
Journal:  Retina       Date:  2015-02       Impact factor: 4.256

Review 5.  Interphotoreceptor retinoid-binding protein (IRBP). Molecular biology and physiological role in the visual cycle of rhodopsin.

Authors:  D R Pepperberg; T L Okajima; B Wiggert; H Ripps; R K Crouch; G J Chader
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

6.  Use of high spatial resolution perimetry to identify scotomata not apparent with conventional perimetry in the nasal field of glaucomatous subjects.

Authors:  M C Westcott; D F Garway-Heath; F W Fitzke; D Kamal; R A Hitchings
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

7.  Topographic Variation of the Growth Rate of Geographic Atrophy in Nonexudative Age-Related Macular Degeneration: A Systematic Review and Meta-analysis.

Authors:  Liangbo L Shen; Mengyuan Sun; Sumun Khetpal; Holly K Grossetta Nardini; Lucian V Del Priore
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-01-23       Impact factor: 4.925

8.  Long-Term Effects of Half-Time Photodynamic Therapy on Retinal Sensitivity in Eyes with Chronic Central Serous Chorioretinopathy.

Authors:  Takehito Iwase; Hirotaka Yokouchi; Masayasu Kitahashi; Mariko Kubota-Taniai; Takayuki Baba; Shuichi Yamamoto
Journal:  Biomed Res Int       Date:  2020-08-17       Impact factor: 3.411

9.  Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy.

Authors:  Kyoko Fujita; Kei Shinoda; Celso Soiti Matsumoto; Yutaka Imamura; Etsuko Tanaka; Yoshihiro Mizutani; Atsushi Mizota; Mitsuko Yuzawa
Journal:  Clin Ophthalmol       Date:  2012-10-16

10.  Macular Integrity Assessment and Fixation Analysis in Chronic Central Serous Chorioretinopathy.

Authors:  Joanna Dolar-Szczasny; Anna Święch-Zubilewicz; Jerzy Mackiewicz
Journal:  J Ophthalmol       Date:  2018-03-14       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.